Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Dr.Reddy's Laboratories Ltd (NYSE:RDY)

40.91
Delayed Data
As of Apr 24
 +0.34 / +0.84%
Today’s Change
39.04
Today|||52-Week Range
54.73
-9.65%
Year-to-Date
New Strong Sell Stocks for April 20th
Apr 20 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for April 11th
Apr 11 / Zacks.com - Paid Partner Content
Mylan Down on FDA Warning Letter to Manufacturing Facility
Apr 12 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close40.57
Today’s open40.60
Day’s range40.25 - 40.96
Volume267,772
Average volume (3 months)272,883
Market cap$6.7B
Dividend yield0.73%
Data as of 4:02pm ET, 04/24/2017

Growth & Valuation

Earnings growth (last year)-15.85%
Earnings growth (this year)--
Earnings growth (next 5 years)+13.67%
Revenue growth (last year)-2.51%
P/E ratio0.7
Price/Sales3.28
Price/Book3.57

Competitors

 Today’s
change
Today’s
% change
TSROTESARO Inc+1.14+0.84%
IONSIonis Pharmaceutical...+1.48+3.34%
UTHRUnited Therapeutics ...+1.73+1.43%
GRFSGrifols SA+0.31+1.55%
Data as of 3:59pm ET, 04/24/2017

Financials

Next reporting dateMay 16, 2017
EPS forecast (this quarter)$0.37
Annual revenue (last year)$2.4B
Annual profit (last year)$305.0M
Net profit margin12.94%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Co-Chairman, Chief Executive Officer &
MD
Gunupati Venkateswara Prasad
President, CFO &
Global Head-IT
Saumen Chakraborty
Corporate headquarters
Hyderabad, Telangana

Forecasts


Search for Jobs